Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04097158 · ClinicalTrials.gov registry record

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Loma Linda University.

Recruiting
Registry status
160
Enrollment target
1
Study location

NCT04097158 is a study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 160 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04097158, a study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Loma Linda University.

RECRUITING
Registry status
160 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to help the investigators better understand how the new FDA approved medication Edaravone (also known as Radicava) works in subsets of patients with ALS. The investigators are also trying to understand if there are specific ALS patients, with different presentations of ALS, who might benefit most from this medication. Also, the investigators are following specific biomarkers to determine the optimal treatment duration in patients with different forms of ALS There is no study medication being offered in this trial. Edaravone is prescribed as part of regular care. In this trial we are collecting blood, urine, and spinal fluid samples in ALS patients who are taking Edaravone and ALS patients who are not taking Edaravone to measure certain markers that could indicate why the drug may be working in a specific type of ALS.

Conditions Studied

Amyotrophic Lateral Sclerosis

Interventions

  • OTHER Sample Collection

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2019-10-08
Est. Completion 2026-04

Sponsor

Loma Linda University

237 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04097158

The ClinicalTrials.gov registry entry for NCT04097158 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (82% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Sample Collection is the first listed.

NCT04097158 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04097158 about?

NCT04097158 is a clinical study titled "Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone". This study is being conducted to help the investigators better understand how the new FDA approved medication Edaravone (also known as Radicava) works in subsets of patients with ALS. The investigators are also trying to understand if there are specific ALS patients, with different presentations of ...

What is the current status of trial NCT04097158?

This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2019-10-08. Estimated completion is 2026-04.

What conditions does trial NCT04097158 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

What interventions are being tested in trial NCT04097158?

The interventions under investigation include: Sample Collection (OTHER).

Who is sponsoring clinical trial NCT04097158?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04097158 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.